Littoral cell angioma of the spleen revealed by a Kasabach-Merritt syndrome in a 22-month-old child
Abstract
Keywords
Full Text:
PDFReferences
Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002; 24(6):459-462.
Verheul HMW, Panigrahy D, Flynn E, et al. Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: elevated platelet counts, prolonged survival, and tumor growth inhibition. Pediatr Res 1999; 46:562-565.
O’Rafferty C, O’Regan GM, Irvin AD, et al. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon. Br J Haematol 2015; 171(1):38-51.
Croteau SE, Liang MG, Kozakewich HP, et al. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr 2013; 162(1):142-147.
Falk S, Stutte HJ, Frizzera G. Littoral cell angioma: a novel splenic vascular lesion demonstrating histiocytic differentiation. Am J Surg Pathol 1991; 15(11):1023-1033.
Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 1940; 59:1063-1070.
Haque PD, Mahajan A, Chaudhary NK, et al. Kasabach-Merritt syndrome associated with a large cavernous splenic hemangioma treated with splenectomy: a surgeon’s introspection of an uncommon, little read, and yet complex problem. Indian J Surg 2015; 77(1):166-169.
Louis TH, Sanders JM, Stephenson JS, et al. Splenic hemangiomatosis. Proc Bayl Univ Med Cent 2011; 24(4):356-358.
Enjolras O, Mulliken JB, Wassef M, et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000; 42(2):225-235.
Taeguyn K, Mi Ryung R, Kee Yang C, et al. Kasabach-Merritt Syndrom arising from a tufted angioma successfully treated with systemic corticosteroid. Ann Dermatol 2010; 22(4):426-430.
Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001; 112(4):851-862.
Mizutani K, Umaoka A, Tsuda K, et al. Successful combination therapy of propranolol and prednisolone for a case with congenital Kasabach-Merritt syndrome. J Dermatol 2017; doi: 10.1111/1346-8138.13984.
Wang Z, Li K, Dong K, et al. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma and Kasabach-Merritt syndrome. Pediatr Blood Cancer 2014; 61:1518-1519.
Wang Z, Li K, Dong K, et al. Refractory Kasabach-Merritt phenomenon successfully treated with sirolimus and a mini-review of the published work. J Dermatol 2015; 42(4):401-404.
Wang Z, Li K, Dong K, et al. Successful treatment of Kasabach-Merritt phenomenon arising from kaposiform hemangio-endotheliomas by sirolimus. J Pediatr Hematol Oncol 2015; 37(1):72-73.
Ji Y, Chen S, Xiang B, et al: Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: a multicenter retrospective study. Int J Cancer 2017; 141(4):848-855.
Delgado M, Pérez-Ruiz E, Alcade J, et al. Anti-angiogenic treatment (Sunitinib) for disseminated malignant haemangiopericytoma: a case study and review of the literature. Case Rep Oncol 2011; 4(1):55-59.
Phillips WG, Marsden JR. Kasabach-Merritt syndrome exacerbated by platelet transfusion. J R Soc Med 1993; 86(4):231–232.
Tee M, Vos P, Wiseman S, et al. Incidental littoral cell angioma of the spleen. World J Surg Oncol 2008; 6:87.
Bisceglia M, Sickel JZ, Giangaspero F, et al. Littoral cell angioma of the spleen: an additional report of four cases with emphasis on the association with visceral organ cancers. Tumori 1998; 84(5):595-599.
DOI: http://dx.doi.org/10.22551/2017.17.0404.10112
Copyright (c) 2017 Marie-Amelyne Le Rouzic, Julie Valduga, Aurélie Phulpin-Weibel, Ludovic Mansuy, Audrey Contet, Fanny Fouyssac, Imane Athmani, Marie-Agnès Galloy, Michel Wassef, Pascal Chastagner
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975